Searched for
GLENMARK PHARMACEUTICALS S.A.
Glenmark Pharma launches generic version of asthma drug in DenmarkThe product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries.16 May, 2018, 10.57 AM IST- Glenmark's novel antibody GBR 1302 to enter clinical trialsGlenmark has completed the pre-clinical evaluation for its bi-specific antibody GBR 1302 and filed the phase I trial application for the sa...15 Sep, 2015, 05.06 PM IST
- Glenmark Pharmaceuticals completes phase I clinical trials for antibodyGlenmark Pharmaceuticals has completed the clinical phase I studies for its novel monoclonal antibody 'GBR 830' for treating autoimmune dis...03 Sep, 2015, 07.10 PM IST
- Glenmark Pharmaceuticals discovers new molecule; enters oncology segmentGlenmark announced the discovery and initiation of studies of a novel clinical development candidate, GBR 1302, the company said in a state...20 Aug, 2014, 06.00 PM IST
- Glenmark Pharmaceuticals' new molecule enters human trialsGlenmark Pharmaceuticals S.A., a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals, said GBR 830 is entering human trials.03 Jul, 2014, 08.26 PM IST
- Glenmark opens new manufacturing facility in SwitzerlandGlenmark Pharmaceuticals opened a new manufacturing facility in Switzerland for supply of clinical trial material.04 Jun, 2014, 01.46 PM IST
- Glenmark initiates studies to develop new molecule 'GBR 830'Glenmark Pharmaceuticals initiates studies to develop a new molecule 'GBR 830', which could treat diseases like Arthritis (RA) and bowel di...04 Feb, 2013, 03.57 PM IST
- Glenmark inks drug development pact with Forest LaboratoriesAs part of the agreement, Glenmark will receive up to $ 9 million (around Rs 50 crore) from US-based Forest Laboratories Inc.24 Dec, 2012, 02.44 PM IST
- Glenmark Pharmaceuticals hits 52-week high on pact with Forest LaboratoriesGlenmark surged over 4% to hit its 52-week high of Rs 519.70 after the company said its subsidiary has signed an agreement with Forest Labs.24 Dec, 2012, 12.09 PM IST
- Glenmark enters phase II clinical trial for new drug moleculeGlenmark Pharmaceuticals said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.13 Sep, 2012, 03.26 PM IST
- Glenmark gets $25 mn from Sanofi as final upfront paymentGlenmark Pharmaceuticals today said it has received Rs 110 crore from Sanofi, as second tranche of oulicensing fee for a deal with French d...11 Jul, 2011, 03.41 PM IST
- Glenmark finds molecule for treating blood cancerGlenmark Pharmaceuticals on Thursday said it has discovered a new drug molecule which can treat blood and lymph cancer, besides inflammator...01 Apr, 2011, 02.09 AM IST
- Glenmark surges 12% on BSE on Sanofi-Aventis licensing pactShares of pharma firm Glenmark Pharmaceuticals today vaulted by 12 per cent on the Bombay Stock Exchange to touch a year-high of Rs 303.80 ...03 May, 2010, 11.33 AM IST
- Glenmark seeks action against govt hospital for falsifying dataGlenmark Pharmaceuticals has complained to the drug regulator that the government-funded research centre, Guru Govind Singh Hospital in Jam...24 Apr, 2009, 03.22 PM IST
- Glenmark's Swiss arm gets $15 mn milestone payment from Forest LabsGlenmark Pharmaceuticals SA, the Swiss subsidiary of Glenmark Pharmaceuticals, has received a milestone payment of $15 million from Forest ...06 Feb, 2008, 11.16 AM IST
- Glenmark eyes pain management marketGlenmark Pharmaceuticals on Monday said its Swiss subsidiary has completed phase I clinical trials for GRC 6211, a pain reliever, and plans...28 May, 2007, 03.25 PM IST
- Merck inks pact to develop, sell Glenmark diabetes drugGerman pharma major Merck KGaA and Glenmark Pharmaceuticals SA (Switzerland), a wholly-owned subsidiary of Glenmark Pharma India, announced...18 Oct, 2006, 02.40 AM IST
Load More
